Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Sunday, November 17, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Sunday, November 17, 2024 | Latest Paper
Subscribe Now

TRENDING:

Shana Kelley and Keith Pardee

We need a moonshot for new diagnostics if we want effective pandemic control

  • The COVID-19 pandemic has highlighted how difficult it is to deploy the tools we have on hand to diagnose infectious disease.  Testing reagents have
Opinion | BY SHANA KELLEY AND KEITH PARDEE | May 12, 2020
Innovation Minister Navdeep Bains, pictured addressing reporters on the feds' COVID-19 response. Most venture capital investors avoid diagnostic technology startups as the margins on these products are low, commercialization scale-up costs are high, and it is therefore difficult to get financial returns that investors expect. The Hill Times photograph by Andrew Meade

We need a moonshot for new diagnostics if we want effective pandemic control

Opinion | BY SHANA KELLEY AND KEITH PARDEE | May 12, 2020
  • The COVID-19 pandemic has highlighted how difficult it is to deploy the tools we have on hand to diagnose infectious disease.  Testing reagents have

We need a moonshot for new diagnostics if we want effective pandemic control

Opinion | BY SHANA KELLEY AND KEITH PARDEE | May 12, 2020
  • The COVID-19 pandemic has highlighted how difficult it is to deploy the tools we have on hand to diagnose infectious disease.  Testing reagents have
Innovation Minister Navdeep Bains, pictured addressing reporters on the feds' COVID-19 response. Most venture capital investors avoid diagnostic technology startups as the margins on these products are low, commercialization scale-up costs are high, and it is therefore difficult to get financial returns that investors expect. The Hill Times photograph by Andrew Meade

We need a moonshot for new diagnostics if we want effective pandemic control

  • The COVID-19 pandemic has highlighted how difficult it is to deploy the tools we have on hand to diagnose infectious disease.  Testing reagents have
Opinion | BY SHANA KELLEY AND KEITH PARDEE | May 12, 2020
Innovation Minister Navdeep Bains, pictured addressing reporters on the feds' COVID-19 response. Most venture capital investors avoid diagnostic technology startups as the margins on these products are low, commercialization scale-up costs are high, and it is therefore difficult to get financial returns that investors expect. The Hill Times photograph by Andrew Meade

We need a moonshot for new diagnostics if we want effective pandemic control

Opinion | BY SHANA KELLEY AND KEITH PARDEE | May 12, 2020
  • The COVID-19 pandemic has highlighted how difficult it is to deploy the tools we have on hand to diagnose infectious disease.  Testing reagents have

We need a moonshot for new diagnostics if we want effective pandemic control

Opinion | BY SHANA KELLEY AND KEITH PARDEE | May 12, 2020
  • The COVID-19 pandemic has highlighted how difficult it is to deploy the tools we have on hand to diagnose infectious disease.  Testing reagents have
Innovation Minister Navdeep Bains, pictured addressing reporters on the feds' COVID-19 response. Most venture capital investors avoid diagnostic technology startups as the margins on these products are low, commercialization scale-up costs are high, and it is therefore difficult to get financial returns that investors expect. The Hill Times photograph by Andrew Meade
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu